<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JSC</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Multiple Sclerosis and Related Disorders</journal-title>
      </journal-title-group>
      <issn pub-type="epub">0000-0000</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">JSC-17-1583</article-id>
      <article-categories>
        <subj-group>
          <subject>research-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neurovascular Reactivity after Repeated Attacks in Patients with Multiple Sclerosis </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nevzat</surname>
            <given-names>Uzuner</given-names>
          </name>
          <xref ref-type="aff" rid="idm1808926780">1</xref>
          <xref ref-type="aff" rid="idm1808940652">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gulnur</surname>
            <given-names>Tekgol Uzuner</given-names>
          </name>
          <xref ref-type="aff" rid="idm1808926780">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1808926780">
        <label>1</label>
        <addr-line>Eskisehir Osmangazi University, Faculty of Medicine, Department of Neurology, Eskisehir, TURKEY</addr-line>
      </aff>
      <aff id="idm1808940652">
        <label>*</label>
        <addr-line>Corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Anne</surname>
            <given-names>VEJUX</given-names>
          </name>
          <xref ref-type="aff" rid="idm1808768636">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1808768636">
        <label>1</label>
        <addr-line>Laboratoire Bio-PeroxIL EA7270, France</addr-line>
      </aff>
      <author-notes>
        <corresp>
  Nevzat Uzuner, MD, <addr-line>Prof. of Neurology, Eskisehir </addr-line><addr-line>Osmangazi</addr-line><addr-line> University, Faculty of Medicine, Department of Neurology, </addr-line><addr-line>Meselik</addr-line><addr-line>, 26480 Eskisehir, TURKEY</addr-line>, Tel: <phone>+90 222 2392979/3650</phone>, E-mail: <email>nevzatuzuner@gmail.com</email></corresp>
        <fn fn-type="conflict" id="idm1808970652">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2017-08-10">
        <day>10</day>
        <month>08</month>
        <year>2017</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>5</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>05</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>07</month>
          <year>2017</year>
        </date>
        <date date-type="online">
          <day>10</day>
          <month>08</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Nevzat Uzuner et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jsc/article/533">This article is available from http://openaccesspub.org/jsc/article/533</self-uri>
      <abstract>
        <sec id="idm1808775260">
          <title>Objectives</title>
          <p>Increased neurovascular (NV) reactivity has been shown in patients with relapsing-remitting multiple sclerosis (RRMS) during the acute exacerbation period. However, the NV reactivity after several attacks is not known. We, therefore, have investigated the patients by transcranial Doppler (TCD) using simple visual stimulation after the repeated attack periods. </p>
        </sec>
        <sec id="idm1808774756">
          <title>Patients and Methods</title>
          <p>Thirty patients (22 females and eight males, mean age 40 years) with RRMS were examined at least two times. The average TCD examination interval was 26.7 months (range 4-120 months). Mean attack number was 3.8 (range 2-8 times), average disease duration was 57 months (range 4-124 months), and average Expanded Disability Status Scale (EDSS) value was 2.5 (range 1-5.5). We performed transcranial Doppler recordings from the P2-segments of both posterior cerebral arteries simultaneously during simple visual stimulation. The NV reactivity was defined as a relative increase of the blood flow velocities during visual stimulation.  </p>
        </sec>
        <sec id="idm1808775188">
          <title>Results</title>
          <p>The NV reactivity to simple visual stimulation was significantly lower in the second test on both sides (31.5±9.2% and 29.2±7.2%; right and left side, respectively) from those of the first test (38.3±11.9% and 36.0±11.9%; right and left side, respectively) (p&lt;0.001). </p>
        </sec>
        <sec id="idm1808774684">
          <title>Conclusion</title>
          <p>The present study is the first study examining neurovascular reactivity in patients with RRMS during repeated attacks using the transcranial Doppler to our best knowledge. Our results suggest patients with RRMS after repeated exacerbation periods have less reactive neurovascular units in the occipital cortex. The possible explanation might be the repeated demyelination, and insufficient remyelination with longer disease duration may lead glial dysfunction resulting neurovascular unit impairment. If so, functional TCD may be useful for the determining of the disease progression. However, the exact cut-off point is not known. </p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Multiple sclerosis</kwd>
        <kwd>ultrasound</kwd>
        <kwd>visual stimulation</kwd>
        <kwd>neurovascular reactivity.</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="1"/>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1808771876" sec-type="intro">
      <title>Introduction</title>
      <p>Multiple sclerosis (MS) is a chronic disease containing the inflammatory, demyelinating, and degenerative processes of the central nervous system <xref ref-type="bibr" rid="ridm1816030428">1</xref>. The inflammation, microglial activation, astrocytic gliosis, demyelination, and somewhat axonal loss in white matter and grey matter was present in the brains of the patients with MS <xref ref-type="bibr" rid="ridm1816038540">2</xref>. Moreover, MS patients presented a reduction in the cerebral blood flow (CBF) affecting both grey and white matter in positron emission tomography (PET) studies<xref ref-type="bibr" rid="ridm1816108492">3</xref>.</p>
      <p>There is a physical relationship between the neuronal activity and regional cerebral blood flow (CBF) related to the metabolic demand<xref ref-type="bibr" rid="ridm1815896924">4</xref><xref ref-type="bibr" rid="ridm1815894476">5</xref>. Transcranial Doppler provides information regarding blood flow velocity changes in individual cerebral arteries as representative of CBF to visual stimulation<xref ref-type="bibr" rid="ridm1815893036">6</xref><xref ref-type="bibr" rid="ridm1815879516">7</xref>. Besides, the studies evaluating the NV in patients with RRMS have indicated hyperactivity to visual stimulation during the attack, and after high-dose intravenous corticosteroid treatment<xref ref-type="bibr" rid="ridm1815883620">8</xref><xref ref-type="bibr" rid="ridm1815868644">9</xref><xref ref-type="bibr" rid="ridm1815872532">10</xref>. However, it is not known which is this reactivity is subject to change after several exacerbation periods of the disease. In the present study, we assessed the NV reactivity in patients with RRMS after the several repeated exacerbation periods, by the visually evoked CBF velocity changes in both posterior cerebral arteries (PCA) using TCD monitoring.</p>
      <sec id="idm1808772596">
        <title>Patients and Methods: </title>
        <p>Thirty patients (22 females and eight males, mean age 40.1±8.7 years) with RRMS who were admitted to our Neurosonology laboratory during an exacerbation period of the disease were examined at least two times. An exacerbation was defined as a rapid worsening of the symptoms lasting for more than one day in a particular area. The diagnosis of RRMS was determined according to McDonald criteria<xref ref-type="bibr" rid="ridm1815844748">11</xref>.</p>
        <p>All patients were examined clinically, and haematological investigations were performed on all of them. The Expanded DisabilityStatus Scale (EDSS) was also routinely calculated for all the patients<xref ref-type="bibr" rid="ridm1815853820">12</xref>. The cerebral MRI examinations were conducted on all the patients. All subjects had a normal extracranial ultrasound examination. The evaluation of extracranial vessels was carried out by Duplex Color-coded ultra-sonography (Acuson X150, Siemens Medical Solutions, USA). The written confirmations from the Local Clinical Research Ethics Committee were received for this study. </p>
        <p>The TCD examination was performed within the first three days of an acute exacerbation and before any treatment. All TCD and Duplex Sonography examinations were done by the same person (NU), and the same machine was used in this study. The examiner was blinded to disease characteristics of the patients and to study timeline at the time of the examination. Caffeine and nicotine use before TCD examination was not allowed. Although cardiovascular risk factors were not estimated according to the  Framingham Cardiovascular Risk Score<xref ref-type="bibr" rid="ridm1815852956">13</xref>. Subjects lay comfortably in a quiet room. We used a four-channel TCD (DWL Multidop X) with 2-MHz pulsed-wave Doppler transducers affixed to a headband. We performed transtemporal TCD recordings from the P2-segments of both PCAs simultaneously during visual stimulation. The vessels were identified according to the criteria described earlier <xref ref-type="bibr" rid="ridm1815816804">14</xref>. Briefly, through the temporal bone both P2 segments of PCA’s (flow direction away from the probe) were insonated at a depth of 58–68 mm. The verified PCA insonation was required to assess the velocity increase on both sides during the measurement of the visually evoked flow when the patients’ eyes were open as opposed to being closed.</p>
        <p>The simple visual stimulation was performed with a black and white checkerboard. The full instrumentation of the simple visual stimulation has been published elsewhere<xref ref-type="bibr" rid="ridm1815815292">15</xref>. </p>
        <p>The analysis of the visually evoked flow response was performed offline. NV reactivity was defined as a relative increase of the blood flow velocities as a percentage change of the baseline values <sup>NVR = 100*(Vs</sup>. Where Vs indicates the maximum velocity at stimulation (eyes open and stimulus on); the Vr, the minimum velocity at rest (eyes closed) (Figure 1). They are calculated by the special software of the TCD system that allows trigger-related blood flow velocity is averaging<xref ref-type="bibr" rid="ridm1815809028">16</xref>.</p>
        <p>The mean number of the attacks were 3.8 (range 2-8 times), and the mean disease duration was 57 months (range 14-124 months) at the date of the Doppler examination. The EDSS values of the patients were 2.5 (range 1.0–5.5). Twenty patients had mono or hemiparesis, 2 had paraparesis, 8 had ataxia, 22 had sensory disturbances, 7 had optic neuritis, and 2 had diplopia. A combination of more than two symptoms was present in most patients. NV reactivity to simple visual stimulation of patients with optic neuritis only (2 patients) was not significantly different from those of other patients, and therefore, this data was not excluded in the analysis.</p>
        <p>A paired t-test for the samples was applied for statistical analysis, where appropriate, and p &lt; 0.05 was accepted as the statistical significance.</p>
      </sec>
    </sec>
    <sec id="idm1808758140" sec-type="results">
      <title>Results: </title>
      <p>The visual stimulation led to a significant blood flow velocity increase (NVC) on both sides (p &lt; 0.001) in all the subjects. All Doppler data for the visual stimulation group is given in <xref ref-type="table" rid="idm1808264668">Table 1</xref>. </p>
      <table-wrap id="idm1808264668">
        <label>Table 1.</label>
        <caption>
          <title> Doppler data of the patient</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td/>
              <td>First test</td>
              <td>Second test</td>
              <td>P value</td>
            </tr>
            <tr>
              <td>Right-hand side</td>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>Maximum velocity (cm/s) </td>
              <td>49.6±12.0</td>
              <td>45.4±10.2</td>
              <td>0.086</td>
            </tr>
            <tr>
              <td>Minimum velocity (cm/s)</td>
              <td>36.2±9.9</td>
              <td>34.8±8.9</td>
              <td>0.478</td>
            </tr>
            <tr>
              <td>Reactivity (%)</td>
              <td>38.3±11.9</td>
              <td>31.5±9.2</td>
              <td>0.001</td>
            </tr>
            <tr>
              <td>Left-hand side</td>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>Maximum velocity (cm/s) </td>
              <td>47.9±10.0</td>
              <td>46.4±8.4</td>
              <td>0.352</td>
            </tr>
            <tr>
              <td>Minimum velocity (cm/s)</td>
              <td>35.4±7.9</td>
              <td>35.9±6.9</td>
              <td>0.618</td>
            </tr>
            <tr>
              <td>Reactivity (%)</td>
              <td>36.0±11.9</td>
              <td>29.2±7.2</td>
              <td>0.001</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1808727404">
            <label/>
            <p>Values are mean±SD, paired sample t-test</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The NV reactivity to simple visual stimulation was significantly lower in the second test on both sides (31.5±9.2% and 29.2±7.2%; right and left side, respectively) from those of the first test (38.3±11.9% and 36.0±11.9%; right and left side, respectively) (p&lt;0.001).</p>
    </sec>
    <sec id="idm1808725100" sec-type="discussion">
      <title>Discussion</title>
      <p>Normal brain activity is subject to a continuous supply of oxygen and glucose, and local brain activity has to be gone together with an increase in local CBF. The signalling from the neurones to the local vessels are necessary for the local CBF to increase. Also, glial activation plays a role in the neurovascular coupling; especially visual stimulation<xref ref-type="bibr" rid="ridm1815894476">5</xref><xref ref-type="bibr" rid="ridm1815822852">17</xref>. Endothelial cells and pericytes are also involved in the neurovascular reactivity<xref ref-type="bibr" rid="ridm1815818964">18</xref>. However, the exact coupling mechanism of the neurovascular unit is not yet fully understood. </p>
      <p>Also, neurovascular reactivity can be affected by different concomitant factors<xref ref-type="bibr" rid="ridm1815852956">13</xref>.</p>
      <p>The cerebrovascular reactivity can be measured by TCD, which allows for the real-time investigation of the velocity changes after the breath holding test <xref ref-type="bibr" rid="ridm1815799692">19</xref><xref ref-type="bibr" rid="ridm1815796668">20</xref>. Normal cerebrovascular reactivity using a breath-holding test or tilt-table test in MS patients was published <xref ref-type="bibr" rid="ridm1815793356">21</xref><xref ref-type="bibr" rid="ridm1815791628">22</xref>. </p>
      <p>The results of the previous studies assessing NV reactivity in MS patients have shown hyperactivity to visual stimulation during an attack and just after a high-dose of intravenous corticosteroid treatment <xref ref-type="bibr" rid="ridm1815883620">8</xref><xref ref-type="bibr" rid="ridm1815868644">9</xref><xref ref-type="bibr" rid="ridm1815872532">10</xref><xref ref-type="bibr" rid="ridm1815852956">13</xref>. Their conclusion was that this hyperactivity might be a result of the adaptive changes in the occipital cortical neurones due to long-term inhibition caused by axonal injury and demyelination. </p>
      <p>To our best knowledge, the present study is the first one examining neurovascular reactivity in patients with RRMS after repeated attacks using the transcranial Doppler. However, the small number of cases and the variation of the second test whether about the number of attacks or relation to the disease duration are the important limitations of our study. Nonetheless, our results suggest patients with RRMS after repeated exacerbation periods have less reactive neurovascular units in the occipital cortex. The possible explanation might be the repeated demyelination, and insufficient remyelination with longer disease duration may lead not only neuronal dysfunction but also the impaired glial dysfunction. Due to limitations of the present study, we recommend a larger study with an adequate number of patients to support our explanation. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1816030428">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Frischer</surname>
            <given-names>J M</given-names>
          </name>
          <name>
            <surname>Bramow</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dal-Bianco</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lucchinetti</surname>
            <given-names>C F</given-names>
          </name>
          <name>
            <surname>Rauschka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Schidbauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Laursen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sorensen</surname>
            <given-names>P S</given-names>
          </name>
          <name>
            <surname>Lassmann</surname>
            <given-names>H</given-names>
          </name>
          <article-title>The relation between inflammation and neurodegeneration in multiple sclerosis</article-title>
          <date>
            <year>2009</year>
          </date>
          <source>Brain;</source>
          <volume>132</volume>
          <fpage>1175</fpage>
          <lpage>1189</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1816038540">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Wegner</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Esiri</surname>
            <given-names>M M</given-names>
          </name>
          <name>
            <surname>Chance</surname>
            <given-names>S A</given-names>
          </name>
          <name>
            <surname>Palace</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>P M</given-names>
          </name>
          <article-title>Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology</article-title>
          <date>
            <year>2006</year>
          </date>
          <volume>67</volume>
          <fpage>960</fpage>
          <lpage>967</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1816108492">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Okamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hirai</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med</article-title>
          <date>
            <year>1998</year>
          </date>
          <volume>12</volume>
          <fpage>89</fpage>
          <lpage>94</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815896924">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Carmignoto</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gómez-Gonzalo</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The contribution of astrocyte signalling to neurovascular coupling. Brain Res Rev</article-title>
          <date>
            <year>2010</year>
          </date>
          <volume>63</volume>
          <fpage>138</fpage>
          <lpage>148</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815894476">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Petzold</surname>
            <given-names>G C</given-names>
          </name>
          <name>
            <surname>Murthy</surname>
            <given-names>V N</given-names>
          </name>
          <article-title>Role of astrocytes in neurovascular coupling</article-title>
          <date>
            <year>2011</year>
          </date>
          <source>Neuron</source>
          <volume>71</volume>
          <fpage>782</fpage>
          <lpage>797</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815893036">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Aaslid</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Visually evoked dynamic blood flow response of human cerebral circulation. Stroke</article-title>
          <date>
            <year>1987</year>
          </date>
          <volume>18</volume>
          <fpage>771</fpage>
          <lpage>775</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815879516">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ak</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Gücüyener</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Asil</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vardareli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Özdemir</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Cerebral hemodynamic patterns with Technetium-99m-HMPAO SPECT and transcranial Doppler: a validation study using visual stimulation</article-title>
          <date>
            <year>2002</year>
          </date>
          <source>J Ultrasound Med</source>
          <volume>21</volume>
          <fpage>955</fpage>
          <lpage>959</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815883620">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Özkan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gücüyener</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Özdemir</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Cerebral blood flow velocity changes to visual stimuli in patients with multiple sclerosis, Mult Scler</article-title>
          <date>
            <year>2002</year>
          </date>
          <volume>8</volume>
          <fpage>217</fpage>
          <lpage>221</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815868644">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ozkan</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Multiple sclerosis and functional transcranial Doppler, in: Frank Columbus (Ed.), Treatment and Management of Multiple Sclerosis</article-title>
          <date>
            <year>2005</year>
          </date>
          <fpage>253</fpage>
          <lpage>271</lpage>
          <publisher-loc>Nova Publishers, NY</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1815872532">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Ozkan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kutlu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ozbabalık</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ozdemir</surname>
            <given-names>G</given-names>
          </name>
          <article-title>The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis</article-title>
          <date>
            <year>2006</year>
          </date>
          <source>J Clin Neurosci</source>
          <volume>13</volume>
          <issue>2</issue>
          <fpage>214</fpage>
          <lpage>217</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815844748">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>McDonald</surname>
            <given-names>W I</given-names>
          </name>
          <name>
            <surname>Compston</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Edan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Goodkin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hartung</surname>
            <given-names>H P</given-names>
          </name>
          <name>
            <surname>Lublin</surname>
            <given-names>F D</given-names>
          </name>
          <name>
            <surname>McFarland</surname>
            <given-names>H F</given-names>
          </name>
          <name>
            <surname>Paty</surname>
            <given-names>D W</given-names>
          </name>
          <name>
            <surname>Polman</surname>
            <given-names>C P</given-names>
          </name>
          <name>
            <surname>Reingold</surname>
            <given-names>S C</given-names>
          </name>
          <name>
            <surname>Sandberg-Wollheim</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sibley</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Noort</surname>
            <given-names>S van den</given-names>
          </name>
          <name>
            <surname>Weinshenker</surname>
            <given-names>B Y</given-names>
          </name>
          <name>
            <surname>Wolinsky</surname>
            <given-names>J S</given-names>
          </name>
          <article-title>Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol</article-title>
          <date>
            <year>2001</year>
          </date>
          <volume>50</volume>
          <fpage>121</fpage>
          <lpage>127</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815853820">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Kurtzke</surname>
            <given-names>J F</given-names>
          </name>
          <article-title>Rating neurologic impairment in multiple sclerosis: an expanded disability rating scale (EDSS). Neurology</article-title>
          <date>
            <year>1983</year>
          </date>
          <volume>33</volume>
          <fpage>1444</fpage>
          <lpage>1452</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815852956">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Moccia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lanzillo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Palladino</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maniscalco</surname>
            <given-names>G T</given-names>
          </name>
          <name>
            <surname>A</surname>
            <given-names>De Rosa</given-names>
          </name>
          <name>
            <surname>Russo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Massarelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Carotenuto</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Postiglione</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Caporale</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Triassi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Morra</surname>
            <given-names>V B</given-names>
          </name>
          <article-title>The Framingham cardiovascular risk score in multiple sclerosis</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>European Journal of Neurology</source>
          <volume>22</volume>
          <fpage>1176</fpage>
          <lpage>1183</lpage>
          <pub-id pub-id-type="doi">10.1111/ene.12720</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1815816804">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Fujioka</surname>
            <given-names>K A</given-names>
          </name>
          <name>
            <surname>Douville</surname>
            <given-names>C M</given-names>
          </name>
          <article-title>Anatomy and freehand techniques, in:</article-title>
          <date>
            <year>1983</year>
          </date>
          <source>Newell DW, Aaslid R (Eds.), Transcranial Doppler.RavenPressPublishers,New York,USA</source>
          <fpage>9</fpage>
          <lpage>31</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815815292">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Tekgöl</surname>
            <given-names>Uzuner G</given-names>
          </name>
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Neurovascular coupling in patients with relapsing-remitting multiple sclerosis</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Clin Neurol Neurosurg;</source>
          <volume>146</volume>
          <fpage>24</fpage>
          <lpage>28</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815809028">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Sturzenegger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Newell</surname>
            <given-names>D W</given-names>
          </name>
          <name>
            <surname>Aaslid</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Visually evoked blood flow response assessed by simultaneous two-channel transcranial Doppler using flow velocity averaging</article-title>
          <date>
            <year>1996</year>
          </date>
          <source>Stroke;</source>
          <volume>27</volume>
          <fpage>2256</fpage>
          <lpage>2261</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815822852">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Metea</surname>
            <given-names>M R</given-names>
          </name>
          <name>
            <surname>Newman</surname>
            <given-names>E A</given-names>
          </name>
          <article-title>Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling</article-title>
          <date>
            <year>2006</year>
          </date>
          <source>J Neurosci</source>
          <volume>26</volume>
          <issue>11</issue>
          <fpage>2862</fpage>
          <lpage>2870</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815818964">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Peppiatt</surname>
            <given-names>C M</given-names>
          </name>
          <name>
            <surname>Howarth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mobbs</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Attwell</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Bidirectional control of CNS capillary diameter by pericytes</article-title>
          <date>
            <year>2006</year>
          </date>
          <source>Nature;</source>
          <volume>443</volume>
          <fpage>700</fpage>
          <lpage>704</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815799692">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Johnston</surname>
            <given-names>A J</given-names>
          </name>
          <name>
            <surname>Steiner</surname>
            <given-names>L A</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>A K</given-names>
          </name>
          <name>
            <surname>Menon</surname>
            <given-names>D K</given-names>
          </name>
          <article-title>Cerebral oxygen vasoreactivity and cerebral tissue oxygen reactivity</article-title>
          <date>
            <year>2003</year>
          </date>
          <source>Br J Anaesth</source>
          <volume>90</volume>
          <fpage>774</fpage>
          <lpage>786</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815796668">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Markus</surname>
            <given-names>H S</given-names>
          </name>
          <name>
            <surname>Harrison</surname>
            <given-names>M J</given-names>
          </name>
          <article-title>Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath holding as the vasodilator stimulus. Stroke</article-title>
          <date>
            <year>1992</year>
          </date>
          <volume>23</volume>
          <fpage>668</fpage>
          <lpage>673</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815793356">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Uzuner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ozkan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cinar</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Cerebrovascular reactivity in multiple sclerosis patients. Mult Scler</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>13</volume>
          <fpage>737</fpage>
          <lpage>741</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1815791628">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mezei</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Olah</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kardos</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kovacs</surname>
            <given-names>R K</given-names>
          </name>
          <name>
            <surname>Csiba</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Csepany</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment</article-title>
          <date>
            <year>2013</year>
          </date>
          <source>J Neurol;</source>
          <volume>260</volume>
          <fpage>2335</fpage>
          <lpage>2342</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
